SEC Form 4 · accession 0000886163-16-000211

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP, Gen. Counsel & Secretary

Period of report

Aug 5, 2016

Accepted (ET)

Aug 9, 2016 · 4:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000886163

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 5, 2016	M	4,295	$21.92	A	33,942	D
Common Stock	Aug 5, 2016	S	4,295	$123.16	D	29,647	D
Common Stock	Aug 5, 2016	M	5,688	$56.26	A	35,335	D
Common Stock	Aug 5, 2016	S	5,688	$123.16	D	29,647	D
Common Stock	Aug 5, 2016	M	12,084	$74.42	A	41,731	D
Common Stock	Aug 5, 2016	S	12,084	$123.16	D	29,647	D
Common Stock	Aug 5, 2016	M	4,947	$42.90	A	34,594	D
Common Stock	Aug 5, 2016	M	3,333	$40.86	A	37,927	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$40.86	Aug 5, 2016	M	3,333	D	—	Apr 30, 2017	Common Stock	3,333	0	D
Employee Stock Option (right to buy)^F2	$42.90	Aug 5, 2016	M	4,947	D	—	Jun 20, 2017	Common Stock	4,947	0	D
Employee Stock Option (right to buy)^F3	$56.26	Aug 5, 2016	M	5,688	D	—	Feb 10, 2025	Common Stock	5,688	10,369	D
Employee Stock Option (right to buy)^F4	$74.42	Aug 5, 2016	M	12,084	D	—	Feb 12, 2024	Common Stock	12,084	7,916	D
Non-Qualified Stock Option (right to buy)^F5	$21.92	Aug 5, 2016	M	4,295	D	—	Feb 15, 2023	Common Stock	4,295	469	D

F1Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 4/30/07.
F2Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 6/20/07.
F3Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/10/15.
F4Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/12/14.
F5Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/13.